Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Nivolumab

Type 1 diabetes and subcutaneous fat necrosis: case report

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Bhargava P, et al. Nivolumab-Induced Subcutaneous Fat Necrosis: Another FDG-Avid Immune-Related Adverse Event. Clinical Nuclear Medicine 45: 125-126, No. 2, Feb 2020. Available from: URL: http://doi.org/10.1097/RLU.0000000000002862

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Nivolumab. Reactions Weekly 1791, 200 (2020). https://doi.org/10.1007/s40278-020-75045-6

    Download citation